Grace Therapeutics's total assets for Q1 2027 were C$50.07M, a decrease of -24.88% from the previous quarter. DE:L8S total liabilities were C$1.86M for the fiscal quarter, a -32.49% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.